Search results
Results from the WOW.Com Content Network
This article originally appeared on Medical News Today The use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss has been greatly increasing.
As the GLP-1 patients in Al-Aly’s study were all veterans, with full drug coverage, their retention rate was higher—roughly 70% after a year. How the study’s results will be interpreted or ...
A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. ... calls the latest findings “good news.” ... USA TODAY Sports.
This article originally appeared on Medical News Today GLP-1 drugs such as Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide) may offer benefits that extend beyond aiding in weight loss ...
A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health ...
GLP-1 agonist drugs like Ozempic, ... This article originally appeared on Medical News Today. About 12.2 million new strokes are diagnosed each year.
On the flip side, the study found that these drugs, known as GLP-1s, are also associated with an increased risk of several negative health outcomes and side effects. The most common were the well ...
"We still like them, and the reaction last week [to CagriSema news] was a bit overdone, but we cut our price targets significantly," Seigerman said. BMO cut its price target for Novo from $156 per ...